Certificates Of Analysis

BPC157 10mg 31Jul2025 _ (9.803mg - 99.79%) HPLC

Ipamorelin 10mg 31Jul2025 _ (10.21mg - 99.66%) HPLC

Retatrutide 30mg 31Jul2025 _ (32.49mg - 99.49%) HPLC

Tesamorelin 10mg 31Jul2025 _ (10.38mg - 96.99%) HPLC

Tirzepatide 20mg 31Jul2025 _ (21.32mg - 99.55%) HPLC

DSIP 8Sep2025 _ (99.96%) HPLC

GHRP2 5mg 8Sep2025 _ (99.87%) HPLC

GHRP2 10mg 8Sep2025 _ (99.84%) HPLC

GHRP6 5mg 8Sep2025 _ (99.97%) HPLC

GHRP6 10mg 8Sep2025 _ (99.94%) HPLC

GLOW 8Sep2025 _ (99.94%) HPLC

Kisspeptin 8Sep2025 _ (99.97%) HPLC

KLOW 8Sep2025 _ (99.96%) HPLC

KPV 8Sep2025 _ (99.96%) HPLC

MOTS-C 8Sep2025 _ (99.68%) HPLC

MT-1 8Sep2025 _ (99.98%) HPLC

NAD+ 8Sep2025 _ (99.87%) HPLC

SS-31 8Sep2025 _ (99.03%) HPLC

Thymalin 8Sep2025 _ (99.93%) HPLC

VIP 8Sep2025 _ (99.95%) HPLC

Certificates of Analysis (CoA) are essential documents that provide detailed information about the quality and composition of peptides. These certificates are critical in the peptide industry, as they ensure that products meet specified standards and are safe for consumption.

A Certificate of Analysis typically includes several key components. First, it outlines the identity of the peptide, confirming that the product is what it claims to be. This is achieved through various analytical techniques, such as mass spectrometry or high-performance liquid chromatography (HPLC), which can accurately determine the molecular weight and structure of the peptide.

Second, the CoA provides quantitative data regarding the concentration of the active ingredient. This is crucial for users who require precise dosages for therapeutic or performance-enhancing purposes. For instance, a peptide may be required to contain a specific percentage of active compounds to be effective. The CoA will indicate this concentration, often expressed as a percentage or in milligrams per milliliter.

Additionally, the CoA includes information on purity levels. High-purity peptides are essential for ensuring efficacy and minimizing the risk of adverse effects. A typical purity standard for research-grade peptides is 95% or higher. The CoA will specify the purity level, often determined through methods such as HPLC or capillary electrophoresis.

Another critical aspect of the CoA is the presence of any contaminants or impurities. This may include residual solvents, heavy metals, or microbial contamination. The CoA will detail the tests conducted to assess these factors, ensuring that the peptide is safe for use. Regulatory standards often dictate acceptable limits for these contaminants, which must be adhered to in order to maintain product integrity.

Furthermore, the CoA may also include stability data, indicating how the peptide performs over time under various storage conditions. This information is vital for both manufacturers and consumers, as it informs them about the shelf life and optimal storage practices for maintaining peptide efficacy.

In summary, Certificates of Analysis are a fundamental component of the peptide industry, providing transparency and assurance regarding product quality. They serve as a critical tool for researchers, healthcare professionals, and consumers alike, ensuring that peptides are both effective and safe for their intended applications. Understanding the details contained within a CoA can significantly enhance the decision-making process when selecting peptide products for health, wellness, or performance enhancement.